• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

Savannah River Site

Monitors a host of energy and nuclear issues from a public interest perspective

  • Home
  • About Us
  • News
  • SRS Watch News
  • Library
    • Department of Energy
    • General Documents
    • Freedom of Information Act Documents
  • Photos
  • Show Search
Hide Search

Has an adequate drug testing program finally been implemented at the MOX boondoggle? Or do problems continue?

SRSW · October 31, 2016 ·

Due to reports that some workers for CB&I AREVA MOX Services (and subcontractors) at the MOX plant were faking urine tests in order to appear drug-free and that the contractor was not implementing a proper drug-testing program, we have heard that more stringent hair follicle testing has finally been implemented at the MOX boondoggle.

Early this year, SRS Watch received rumors that MOX workers were using fake urine and that testing was “non-random” – clean workers were being more often tested in order to fudge overall statistics.   We raised our concerns at that time and heard nothing back from the US DOE – National Nuclear Security Commission, CB&I AREVA MOX Services  or the Nuclear Regulatory Commission.

But DOE/NNSA affirmed drug testing problems at the MOX debacle in the Fiscal Year 2015 award fee determination for the project.  See SRS Watch new release of April 21, 2016 linked here, with link to award fee narrative and other related documents obtained under a Freedom of Information Act request. The award-fee documents clearly reveals that dug testing was “inadequate”:

During this assessment NNSA found that MOX Services is not implementing random drug testing in a manner  that is compliant with the procedure and is therefore not appropriately providing assurance of a drug free  workplace. NNSA found that the randomness of drug testing is not as random as it should be, as there is  only one person authorized to administer testing and her work schedule is well known. This also results in no random tests being performed for workers on off-shifts such as night shift, weekends, holidays, or the test administrator’s scheduled days off. NNSA also found there are too many allowable excuses for  personnel to avoid being tested, such as failure by supervisors to notify personnel to be tested, employees  located at the Barnwell warehouse and not required to report for testing, employees unable to locate the
test administrator upon arrival, employees being away from the construction zone in a “Remote Worker” location though still on SRS property, to name but a few. For the period January through September 2015, these allowable excuses have resulted in the failure to test approximately 1/2 of the personnel selected for random testing, but more importantly they provide known reasons for use by personnel using illegal drugs to avoid testing. NNSA also found that MOX Services had failed to implement specific Dept. of Transportation drug
testing requirements for teamsters. These issues have resulted in MOX Services’ failure to comply with
10 CFR 707 and 53 FR 11970.
An assessment of the Drug-Free Workplace Program showed that MOX Services does have a project procedure
 that is being followed to maintain a drug-free environment for the MOX Project. Two observations were  noted as suggestions to 1) standardize the Drug-Free Workplace terms and conditions used in subcontracts  and to 2) consider modifying subcontract terms and conditions to name specific drugs (including the failure levels)  if MOX Services deems it appropriate.

We have still not received  a response from the NRC about this troubling drug-testing matter – see May 2, 2016 letter linked here.

NOTE: SRS Watch expects the chronic problems with the MOX drug testing program to be addressed in the Fiscal Year 2016 award fee determination.  Problems with drug testing, as it applies to CB&I AREVA MOX Services and all its contractors – including Superior Air Handling (rumored to have botched HVAC installation) – must be fully resolved!

If you have more information about drug testing at the mismanaged MOX project, including possible implementation of hair follicle testing, please let us know: srswatch@gmail.com

Filed Under: SRS Watch News

Primary Sidebar

Subscribe to Updates via Email

Enter your email address to subscribe to updates and receive notifications of new posts by email.

Recent Posts

  • Imaginary, Risky Small Modular Reactors (SMRs) have No Place in South Carolina Energy Legislation (H 3309)
  • Plutonium Pit Lawsuit: “Grassroots Victory in the Fight against Nuclear Weapons Proliferation”
  • National Nuclear Security Administration’s FY24 “Performance Evaluation Report” for SRS Plutonium “Pit” Plant Reveals Problems: Project Management is “Less than Adequate” and Lacks “Integrated Master Schedule”
  • FOIA Request to SRS for Documents on “DEIA” Deletion
  • “Hot Plutonium Pit Bomb Redux” – Environmental Victory for SRS Watch and Allies Concerning Impact of New Nuclear Weapons Production

Categories

  • Events
  • Latest News
  • SRS Watch News

Archives

  • March 2025
  • February 2025
  • January 2025
  • December 2024
  • November 2024
  • October 2024
  • September 2024
  • May 2024
  • April 2024
  • March 2024
  • February 2024
  • January 2024
  • December 2023
  • November 2023
  • October 2023
  • September 2023
  • August 2023
  • July 2023
  • June 2023
  • May 2023
  • April 2023
  • March 2023
  • February 2023
  • January 2023
  • November 2022
  • October 2022
  • September 2022
  • July 2022
  • June 2022
  • May 2022
  • April 2022
  • March 2022
  • February 2022
  • January 2022
  • December 2021
  • November 2021
  • October 2021
  • September 2021
  • August 2021
  • July 2021
  • June 2021
  • May 2021
  • April 2021
  • March 2021
  • February 2021
  • January 2021
  • December 2020
  • November 2020
  • October 2020
  • September 2020
  • August 2020
  • July 2020
  • June 2020
  • May 2020
  • April 2020
  • March 2020
  • February 2020
  • January 2020
  • December 2019
  • November 2019
  • October 2019
  • September 2019
  • August 2019
  • July 2019
  • June 2019
  • May 2019
  • April 2019
  • March 2019
  • February 2019
  • January 2019
  • December 2018
  • November 2018
  • October 2018
  • September 2018
  • August 2018
  • July 2018
  • June 2018
  • May 2018
  • April 2018
  • March 2018
  • February 2018
  • January 2018
  • December 2017
  • November 2017
  • October 2017
  • September 2017
  • August 2017
  • July 2017
  • June 2017
  • May 2017
  • March 2017
  • February 2017
  • January 2017
  • December 2016
  • November 2016
  • October 2016
  • September 2016
  • August 2016
  • July 2016
  • June 2016
  • May 2016
  • April 2016
  • March 2016
  • February 2016
  • January 2016
  • December 2015
  • November 2015
  • October 2015
  • September 2015
  • August 2015
  • July 2015
  • June 2015
  • May 2015
  • April 2015
  • March 2015
  • February 2015
  • January 2015
  • December 2014
  • November 2014
  • October 2014
  • September 2014
  • August 2014
  • July 2014
  • June 2014
  • May 2014
  • April 2014
  • March 2014

SAVANNAH RIVER SITE WATCH
1112 Florence Street, COLUMBIA, SC 29201  | 803-834-3084  – srswatch@gmail.com

Footer

The information produced on this website is the sole property of SRS Watch unless otherwise noted and may be reproduced or quoted if credit is given to SRS Watch. Materials published on this website are for non-profit public interest purposes only. SRS Watch is a registered corporation in South Carolina and in December 2014 and has obtained non-profit 501(c)(3) public -interest organization status from the IRS. SRS Watch is responsible for all material published on this website. We strive to be accurate in all material produced. For inquiries, comments or corrections, please contact us at srswatch@gmail.com or 803-834-3084. Donations are most welcome and are tax deductible. Mailing address: Savannah River Site Watch, 1112 Florence Street, Columbia, SC 29201. This site or product includes IP2Location LITE data available from https://lite.ip2location.com.

©SRS Watch 2019  All Rights Reserved in All Media.